Access cutting-edge kidney transplant rejection treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access kidney transplant rejection specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant rejection treatment provided free
The main goal of this trial is to evaluate the efficacy of felzartamab compared to placebo in kidney transplant recipients diagnosed with late active or chronic active AMR.
Sponsor: Biogen
Check if you qualify for this kidney transplant rejection clinical trial in San Francisco, CA
If you're searching for kidney transplant rejection treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant rejection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.